156 related articles for article (PubMed ID: 21813170)
1. Cadherins, catenins and cell cycle regulators: impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial.
Singh M; Darcy KM; Brady WE; Clubwala R; Weber Z; Rittenbach JV; Akalin A; Whitney CW; Zaino R; Ramirez NC; Leslie KK
Gynecol Oncol; 2011 Nov; 123(2):320-8. PubMed ID: 21813170
[TBL] [Abstract][Full Text] [Related]
2. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.
Zhai B; Yan HX; Liu SQ; Chen L; Wu MC; Wang HY
World J Gastroenterol; 2008 Oct; 14(37):5665-73. PubMed ID: 18837082
[TBL] [Abstract][Full Text] [Related]
4. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.
Bremnes RM; Veve R; Gabrielson E; Hirsch FR; Baron A; Bemis L; Gemmill RM; Drabkin HA; Franklin WA
J Clin Oncol; 2002 May; 20(10):2417-28. PubMed ID: 12011119
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.
Stefansson IM; Salvesen HB; Akslen LA
J Clin Oncol; 2004 Apr; 22(7):1242-52. PubMed ID: 15051772
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of epithelial growth factor receptor, vascular endothelial growth factor, E-cadherin, and p120 catenin in resected non-small cell lung carcinoma].
Ucvet A; Kul C; Gursoy S; Erbaycu AE; Kaya SO; Dinc ZA; Yucel N
Arch Bronconeumol; 2011 Aug; 47(8):397-402. PubMed ID: 21696876
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
Ramburan A; Hadley GP; Govender D
Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
[TBL] [Abstract][Full Text] [Related]
8. Immune expression of E-cadherin and α, β and γ-Catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas.
Reis ST; Leite KR; Mosconi Neto A; Pontes Júnior J; Viana NI; Antunes AA; Dall'Oglio MF; Srougi M
Int Braz J Urol; 2012; 38(4):466-73. PubMed ID: 22951176
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of E-cadherin and P120 catenin cocktail immunostain in distinguishing DCIS from LCIS.
Li X; Schwartz MR; Ro J; Hamilton CR; Ayala AG; Truong LD; Zhai QJ
Int J Clin Exp Pathol; 2014; 7(5):2551-7. PubMed ID: 24966968
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
[TBL] [Abstract][Full Text] [Related]
13. Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma.
Scholten AN; Aliredjo R; Creutzberg CL; Smit VT
Int J Gynecol Cancer; 2006; 16(3):1379-85. PubMed ID: 16803534
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast.
Dabbs DJ; Kaplai M; Chivukula M; Kanbour A; Kanbour-Shakir A; Carter GJ
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):260-6. PubMed ID: 17721269
[TBL] [Abstract][Full Text] [Related]
15. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
[TBL] [Abstract][Full Text] [Related]
16. APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Kisters N; van Engeland M; Dunselman GA; de Haan J; de Goeij AF; Groothuis PG
Int J Gynecol Cancer; 2004; 14(5):947-56. PubMed ID: 15361208
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma.
Chow V; Yuen AP; Lam KY; Tsao GS; Ho WK; Wei WI
J Cancer Res Clin Oncol; 2001 Jan; 127(1):59-63. PubMed ID: 11206273
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancer.
Garcia del Muro X; Torregrosa A; Muñoz J; Castellsagué X; Condom E; Vigués F; Arance A; Fabra A; Germà JR
Eur J Cancer; 2000 Feb; 36(3):357-62. PubMed ID: 10708937
[TBL] [Abstract][Full Text] [Related]
19. The survival effect of E-cadherin and catenins in colorectal carcinomas.
Filiz AI; Senol Z; Sucullu I; Kurt Y; Demirbas S; Akin ML
Colorectal Dis; 2010 Dec; 12(12):1223-30. PubMed ID: 19575736
[TBL] [Abstract][Full Text] [Related]
20. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
